Computational method helps scientists examine microbes at a larger, more comprehensive scale than previously possible

NIH funds three genome centers nationwide to generate and share data from a million people to improve human health

Initial results reveal more than 760 genetic dependencies across multiple cancers, suggesting opportunities for developing new treatments

The Broad Institute announced April 15 that the United States Patent and Trademark Office has issued the first patent for an engineered CRISPR-Cas9 system that is enabling scientists to modify genes and better understand the biology of living cells and organisms. The institute applied for the patent in concert with the January 3, 2013 publication in Science (Cong, et al.) that described the use of the CRISPR enzyme, Cas9, for genome editing.